271 Results

People

  1. Chi
    Chi
  2. O'Reilly
    O'Reilly
  3. D'Angelica
    D'Angelica
  4. Ginsberg
    Ginsberg
  5. Abrey
    Abrey
  6. Barakat
    Barakat
  7. Fong
    Fong
  8. Mehrara
    Mehrara
  9. Soff
    Soff
  10. Abu-Rustum
    Abu-Rustum

Groups

  1. Department of Medicine (117)
  2. Solid Tumor Oncology Division (83)
  3. Surgery (80)
  4. Radiology, Department of (40)
  5. Survivorship Research (39)
  6. Hematologic Malignancies, Division of (38)
  7. Epidemiology and Biostatistics (35)
  8. Center for Hematologic Malignancies (31)
  9. Biostatistics Service (30)
  10. Center for Pancreatic Cancer Research (27)
  1. "lung embolism"
Formats
  1. Journal Article (259)
  2. Review (7)
  3. Guidelines (2)
  4. Conference Paper (1)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (117)
  2. Solid Tumor Oncology Division (83)
  3. Surgery (80)
  4. Radiology, Department of (40)
  5. Survivorship Research (39)
  6. Hematologic Malignancies, Division of (38)

More Groups

People
  1. Dennis Chi (10)
  2. Eileen O'Reilly (9)
  3. Michael D'Angelica (8)
  4. Michelle Ginsberg (8)
  5. Babak Mehrara (7)
  6. Gerald Soff (7)

More People

Years
  1. 2025 (10)
  2. 2024 (27)
  3. 2023 (11)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (13)

More Years

Publications
  1. Cancer (16)
  2. Gynecologic Oncology (12)
  3. Annals of Surgical Oncology (8)
  4. Clinical Cancer Research (8)
  5. Lancet Oncology (7)
  6. Journal of Surgical Oncology (6)

More Publications

Publishers
  1. Elsevier Inc. (42)
  2. Wiley Blackwell (30)
  3. Springer (25)
  4. Elsevier Science, Inc. (23)
  5. Lippincott Williams & Wilkins (22)
  6. Oxford University Press (13)

More Publishers

Results (271)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: An international, open-label, phase 2 basket study
    Journal Article

    Gounder, M.; Schöffski, P.; Jones, R. L.; Agulnik, M.; Cote, G. M.; Villalobos, V. M.; Attia, S.; Chugh, R.; Chen, T. W. W.; Jahan, T.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Robotic surgery in the frail elderly: Analysis of perioperative outcomes
    Journal Article

    Aloisi, A.; Tseng, J.; Kuhn, T.; Feinberg, J.; Chi, D. S.; Brown, C. L.; Mueller, J. J.; Gardner, G. J.; Zivanovic, O.; Jewell, E. L.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: A randomized, open-label, multicenter, phase 2 study (CENTAURUS)
    Journal Article

    Landgren, C. O.; Chari, A.; Cohen, Y. C.; Spencer, A.; Voorhees, P.; Estell, J. A.; Sandhu, I.; Jenner, M. W.; Williams, C.; Cavo, M.; more...
    Leukemia (2020)

    Fulltext@MSK | Save
  • Emergency room imaging in patients with genitourinary cancers: Analysis of the spectrum of CT findings and their relation to patient outcomes
    Journal Article

    Woo, S.; Bou Ayache, J.; Sawan, P.; Infantino, J.; Gangai, N.; Wibmer, A.; Hricak, H.; Groeger, J. S.; Vargas, H. A.
    Emergency Radiology (2020)

    Fulltext@MSK | Save
  • DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
    Journal Article

    Wudhikarn, K.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; Shah, G. L.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma
    Journal Article

    O'Reilly, E. M.; Barone, D.; Mahalingam, D.; Bekaii-Saab, T.; Shao, S. H.; Wolf, J.; Rosano, M.; Krause, S.; Richards, D. A.; Yu, K. H.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Journal Article

    Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: Interim results from a multicentre, open-label, phase 1b study
    Journal Article

    Sequist, L. V.; Han, J. Y.; Ahn, M. J.; Cho, B. C.; Yu, H.; Kim, S. W.; Yang, J. C. H.; Lee, J. S.; Su, W. C.; Kowalski, D.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • TATTON: A multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
    Journal Article

    Oxnard, G. R.; Yang, J. C. H.; Yu, H.; Kim, S. W.; Saka, H.; Horn, L.; Goto, K.; Ohe, Y.; Mann, H.; Thress, K. S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Ambulatory emergency oncology: A key tenet of future emergency oncology care
    Journal Article

    Cooksley, T.; Marshall, W.; Ahn, S.; Lasserson, D. S.; Marshall, E.; Rice, T. W.; Klotz, A.
    International Journal of Clinical Practice (2020)

    Fulltext@MSK | Save